Effects on health-related quality of life in the randomized, controlled crossover trial ADIRA (Anti-inflammatory Diet In Rheumatoid Arthritis)Show others and affiliations
2021 (English)In: PLOS ONE, E-ISSN 1932-6203, Vol. 16, no 10, article id e0258716
Article in journal (Refereed) Published
Abstract [en]
BACKGROUND: Patients with Rheumatoid Arthritis (RA) often report impaired health-related quality of life (HrQoL) such as difficulties in daily life, pain, fatigue and an affected social life. Even when lowering disease activity, pharmacological treatment does not always resolve these factors.
OBJECTIVE: To investigate if a proposed anti-inflammatory diet improves HrQoL in patients with RA.
DESIGN: In this controlled crossover trial, 50 patients were randomized to start with either an intervention diet (anti-inflammatory) or a control diet (usual Swedish intake) for ten weeks followed by a wash out period before switching to the other diet. Participants received food equivalent to ~1100 kcal/day, five days/week, and instructions to consume similarly for the remaining meals. HrQoL was evaluated using Health Assessment Questionnaire (HAQ), 36-item Short Form Survey (SF-36), Visual Analogue Scales (VAS) for pain, fatigue and morning stiffness, and a time scale for morning stiffness.
RESULTS: Forty-seven participants completed ≥1 diet period and were included in the main analyses. No significant difference between intervention and control diet at end of diet periods was observed for any outcome. However, significant improvements were obtained for SF-36 Physical Functioning (mean:5.79, SE: 2.12, 95% CI: 1.58, 10.01) during the intervention diet period. When excluding participants with anti-rheumatic medication changes, the differences between diet periods increased for most outcomes, favoring the intervention diet period, and the difference for SF-36 Physical Functioning became significant (n = 25, mean:7.90, 95% CI:0.56, 15.24, p = 0.036).
CONCLUSIONS: In main analyses, the proposed anti-inflammatory diet did not significantly improve HrQoL for patients with RA compared to control diet. In sub-analyses, significant improvements in physical functioning were detected. Larger studies with consistent medication use and in populations more affected by the disease may be needed to obtain conclusive evidence.
Place, publisher, year, edition, pages
PLOS , 2021. Vol. 16, no 10, article id e0258716
National Category
Clinical Medicine
Identifiers
URN: urn:nbn:se:oru:diva-95086DOI: 10.1371/journal.pone.0258716ISI: 000729172300069PubMedID: 34648598Scopus ID: 2-s2.0-85117284684OAI: oai:DiVA.org:oru-95086DiVA, id: diva2:1604322
Funder
Forte, Swedish Research Council for Health, Working Life and Welfare
Note
Funding agencies:
Swedish government under the ALF agreement ALFGBG-74630
Lennander Foundation
Sahlgrenska University Hospital Foundations
Inger Bendix Foundation
Gothenburg Region Foundation for Rheumatology Research (GSFR)
2021-10-192021-10-192025-02-18Bibliographically approved